Tranexamic Acid is a medicine used to help stop heavy bleeding. It works by preventing blood from clotting too quickly. It's often given during surgery or for certain types of nosebleeds.
Every report comes from a Lived member, sent anonymously.
Have you tried Tranexamic Acid for Fibroids?
Tranexamic acid is a prescription medicine that reduces bleeding by helping blood clots hold together. It comes in two forms with quite different uses. Tranexamic acid tablets, first sold under the brand name Lysteda and now mostly dispensed as generics, are approved to treat heavy menstrual bleeding that returns with each period. They are taken at home, only on the days of a period, and offer a non-hormonal option for people who want lighter periods without using hormones. The injection, sold as Cyklokapron and as generics, is given into a vein by a clinician. Its use approved by the US Food and Drug Administration (FDA) is short-term protection against bleeding during and after tooth extractions in people with hemophilia, an inherited bleeding disorder. Hospitals also use it widely, outside that approval, for serious bleeding after major injuries, heavy bleeding after childbirth and to reduce blood loss during some operations. Large trials found that giving it early to bleeding trauma patients, and to women bleeding heavily after birth, lowered deaths from bleeding. It does not help every kind of bleeding: in a large trial of people bleeding from the stomach or bowel, it did not reduce deaths and led to more clots in the veins.
When a blood vessel is damaged, the body builds a clot on a mesh of a protein called fibrin. It also runs a cleanup system that dissolves clots once they are no longer needed, and the main enzyme doing that work is plasmin. Tranexamic acid stops plasmin from attaching to fibrin, so clots that have already formed break down more slowly and do a better job of sealing off bleeding. This is why it is called an antifibrinolytic (fibrinolysis means the breakdown of clots). It does not change the number of platelets or the level of clotting factors in the blood, and it cannot replace a clotting factor someone is missing. The lining of the uterus contains clot-dissolving enzymes, and slowing them is how the tablets reduce menstrual blood loss. Because the drug shifts the balance toward keeping clots, its main safety concern is unwanted clots in people who are already at higher risk of them.
For heavy periods, the usual adult dose is two 650 mg tablets (1,300 mg) three times a day, starting when the period begins and continuing for no more than 5 days in a cycle. It is not taken between periods. The tablets can be taken with or without food and should be swallowed whole, not chewed, split or crushed. Do not take more than six tablets in 24 hours, and do not double up to make up for a missed dose. The kidneys clear almost all tranexamic acid from the body, so people with reduced kidney function are prescribed lower doses of either form. The injection is given slowly into a vein by a clinician, because giving it too quickly can lower blood pressure. The dose depends on why it is being given and, for some uses, on body weight. In the hemophilia dental setting it is given just before the extraction and may continue for 2 to 8 days afterward.
With the tablets, the problems reported most often in trials were headache, sinus or nasal congestion, back or stomach pain, muscle and joint aches, muscle cramps and tiredness. Many of these were also common in people taking a placebo, so the medicine accounts for only part of that burden. The injection can cause nausea, vomiting or diarrhea. Dizziness can occur with either form, so avoid driving until you know how it affects you. The most important serious risk is a blood clot. Leg pain, swelling, tenderness, warmth or redness is a reason to stop the medicine and call the prescriber right away. Sudden chest pain or shortness of breath needs emergency care. Vision changes, including changes in how colors look, are also a reason to stop and contact the prescriber promptly, because blockages in the blood vessels of the retina (the light-sensing layer at the back of the eye) have been reported. Severe allergic reactions are rare. Trouble breathing, throat tightness, or swelling of the face, lips or tongue is an emergency: stop the medicine and call 911.
Tranexamic acid tablets must not be used with combined hormonal contraception, meaning birth control pills, patches or rings that contain estrogen. Both raise the risk of blood clots, and clots in veins and arteries, including strokes, have been reported in women using them together. The concern is greatest for people who smoke, especially after age 35, and for people with obesity. The warning concerns estrogen-containing methods, so ask the prescriber which contraception is compatible. The tablets are also not for anyone with a current blood clot, a past clot (including one in the leg, lung, brain or eye), or a condition that makes clotting more likely, such as an inherited clotting disorder or certain heart valve or heart rhythm problems. Tranexamic acid should not be used in people with bleeding around the brain from a burst blood vessel (subarachnoid hemorrhage), where it can cause brain swelling and stroke. The tablets are not intended for use in pregnancy, so tell the prescriber if you become pregnant. A few hospital treatments interact. Tranexamic acid and clot-dissolving drugs such as alteplase work against each other. It is not recommended with certain clotting-factor concentrates used in hemophilia, or with all-trans retinoic acid (a treatment for one type of leukemia), because the risk of clots may rise. The injection carries a boxed warning, the FDA's most prominent kind: it is for use in a vein only. Accidental injection into the spinal area, usually through a mix-up with another injectable drug given at the same time, has caused seizures, dangerous heart rhythms and deaths. Preventing this is the care team's job, but it is a reason the drug is handled with care during procedures.
Before prescribing the tablets, a clinician should look for a cause of heavy bleeding that needs its own treatment, such as a problem in the lining of the uterus. Tranexamic acid makes periods lighter; it does not stop them, regulate the cycle, prevent pregnancy, or treat fibroids or other underlying causes. In the main US trial, the full dose reduced menstrual blood loss by about 39% on average, compared with about 5% on placebo, and people reported fewer limits on their social, leisure and physical activities. Because it works only while it is being taken, it is used again with each period for as long as it is needed. It is one of several options for heavy periods. It avoids hormones and is taken only a few days a month, but reviews suggest a hormonal IUD (the levonorgestrel intrauterine system) may reduce bleeding more. Call the prescriber if bleeding does not improve or gets worse. When the injection is used in hospital for an injury, childbirth or surgery, it is usually a single dose or a short course, and timing matters. In the major trauma trial it was given within 8 hours of injury, and in the childbirth trial the clearest benefit came when it was given within 3 hours of birth.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Tranexamic Acid, what you've noticed, or ask the community a question.